Llew Keltner, Director at Raptor Pharmaceutical Corp (RPTP), sold 967 shares at $6.99 ($7K) on 2012-03-15, disclosed to the SEC on 2012-03-16.
Scheduled sale ($7k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| RPTP | BUY | 2014-06-03 | $837 | — | Filing → |
| RPTP | SELL | 2014-03-11 | $157K | — | Filing → |
| RPTP | SELL | 2014-01-09 | $133K | — | Filing → |